Targeting human telomeric G-quadruplex DNA with oxazole-containing macrocyclic compounds

Area of Science:

• Medicinal Chemistry
• Molecular Biology
• Biophysics

Background:

• Oxazole-containing macrocycles, exemplified by telomestatin, are recognized for their potential as anticancer agents.
• These compounds selectively target G-quadruplex DNA structures, which are implicated in cancer progression.

Purpose of the Study:

• To evaluate the cytotoxic effects of two synthetic hexaoxazole macrocycles (HXDV and HXLV-AC) against human cancer cell lines.
• To elucidate the binding mechanism, thermodynamics, and specificity of these compounds to the human telomeric G-quadruplex.

Main Methods:

• Cytotoxicity assays were performed on human lymphoblast (RPMI 8402) and oral carcinoma (KB3-1) cells.
• G-quadruplex DNA binding studies were conducted to determine mode, stoichiometry, and thermodynamics using biophysical techniques.

Main Results:

• Both HXDV and HXLV-AC demonstrated significant cytotoxicity, with IC50 values between 0.4 and 0.9 µM.
• The compounds exclusively bind to the G-quadruplex form of DNA, not duplex or triplex forms.
• Binding occurs at a 2:1 ligand-to-DNA ratio via a terminal capping mechanism, primarily driven by entropy.

Conclusions:

• HXDV and HXLV-AC are effective G-quadruplex-targeting anticancer agents with specific binding modes.
• The entropy-driven binding mechanism and terminal capping interaction have implications for drug design and telomeric DNA targeting.